Pau Celada
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D1 and D2 receptors.
Journal: European journal of pharmacology
Published: February 14, 2023
Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats.
Journal: The international journal of neuropsychopharmacology
Published: November 08, 2021
Preferential In Vivo Inhibitory Action of Serotonin in Rat Infralimbic versus Prelimbic Cortex: Relevance for Antidepressant Treatments.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: June 10, 2021
Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats.
Journal: Neuropharmacology
Published: May 06, 2020
Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
Journal: Neuropharmacology
Published: June 07, 2019
The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors.
Journal: Neuropharmacology
Published: September 28, 2017
The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: May 02, 2017
Effects of Hallucinogens on Neuronal Activity.
Journal: Current topics in behavioral neurosciences
Published: February 27, 2017
Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS.
Journal: Nature reviews. Drug discovery
Published: November 05, 2016
Last Updated: 09/26/2026